Table 6.
CDHR-NUS +99mTc-MIBI PS | SGD + MGD (136 patients) | CI 95% |
---|---|---|
Sensibility | 91% | 86–95 |
Specificity | 99% | 98–100 |
PPV | 97% | 95–100 |
NPV | 99% | 97–100 |
LR+ | 88.8 | 33.4–235.7 |
LR− | 0.09 | 0.06–0.15 |
CDHR-NUS +99mTc-MIBI PS | SGD + MGD (136 patients) | CI 95% |
---|---|---|
Sensibility | 91% | 86–95 |
Specificity | 99% | 98–100 |
PPV | 97% | 95–100 |
NPV | 99% | 97–100 |
LR+ | 88.8 | 33.4–235.7 |
LR− | 0.09 | 0.06–0.15 |